MCC
DFTX

Money Concepts Capital’s Definium Therapeutics DFTX Stock Holding History

Money Concepts Capital’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Hold
13,000
– – 0.01% 501
2025
Q4 		$174K Hold
13,000
– – 0.01% 509
2025
Q3 		$153K Buy
+13,000
New +$121K 0.01% 460
2023
Q1 		– Sell
-500
Closed -$1.1K – 1946
2022
Q4 		$1.1K Buy
+500
New +$1.39K ﹤0.01% 2858

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Money Concepts Capital's DFTX Position: Q1 2026 in Review

Money Concepts Capital held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 13,000 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #501.

Money Concepts Capital first reported a position in DFTX in Q4 2022 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Money Concepts Capital held 13,000 shares of Definium Therapeutics worth $246K as of Q1 2026.
  • Money Concepts Capital left its Definium Therapeutics share count unchanged in Q1 2026.
  • Definium Therapeutics made up 0.01% of Money Concepts Capital's portfolio in Q1 2026, its #501 holding.
  • Money Concepts Capital first reported a position in Definium Therapeutics in Q4 2022 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Money Concepts Capital's 13F filing for Q1 2026, filed 30 Apr 2026.